Neoleukin Therapeutics
Open
$29.04
Prev. Close
$29.04
High
$29.14
Low
$29.04
Market Snapshot
$453.21M
-4.6
-4.27
131
The company is headquartered in New York City, New York and currently employs 131 full-time employees. The company went IPO on 2014-03-07.
The company is headquartered in New York City, New York and currently employs 131 full-time employees. The company went IPO on 2014-03-07.
Recently from Cashu
Neoleukin Therapeutics: Innovative T-Cell Therapy Advances in Immune-Oncology Research
Neoleukin Therapeutics: Pioneering Developments in Immune-Oncology In recent days, Neoleukin Therapeutics stands poised at the forefront of innovation within the immune-oncology sector, particularly t…
It seems there was no text provided to summarize. Please share the content you'd like me to summarize!
Please provide the text you would like me to summarize, and I'll be happy to help!
Please share the content you'd like summarized, and I'll help create a concise title for you.
Certainly! Please provide the text you would like me to summarize so that I can create the article for you.
Sure! Please provide the content you'd like me to summarize.
Please provide the content you want me to summarize, and I will be happy to assist you!